GSK Investigational Site

Johnstown, Pennsylvania 15905

0 studies enrolling now · 5 studies all time

What they study most

Acellular Pertussis, Asthma, Diphtheria, Herpes Simplex Infection, Measles, Measles-Mumps-Rubella Vaccine, Mumps, Pulmonary Disease, Chronic Obstructive, Rubella, Tetanus

Studies at this site

• Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life — Completed
• Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9 — Completed
• A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• HerpeVac Trial for Young Women — Completed
• 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old — Completed